ALC:NYSE
Alcon AG
74,31Â US$
arrow_downward
-0,26%(-0,19) 1D
74,31Â US$
0,00% (0,00)
bedtimeJashtë orarit
Mbyllur: 20 nën, 4:00:05 m.d., GMT-5 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALC...
Hap
74,16Â US$
I lartë
75,04Â US$
I ulët
74,10Â US$
Kapitalizimi i tregut
31,15Â mld
Vëllimi mesatar
2,43Â mln
Vëllimi
3,42Â mln
Maksimumi 52-javor
87,64Â US$
Minimumi 52-javor
61,84Â US$
Beta
0,87
Aksionet në qarkullim
480,40Â mln
Numri i punonjësve
25 mijë
Hap
74,16Â US$
I lartë
75,04Â US$
I ulët
74,10Â US$
Kapitalizimi i tregut
31,15Â mld
Vëllimi mesatar
2,43Â mln
Vëllimi
3,42Â mln
Maksimumi 52-javor
87,64Â US$
Minimumi 52-javor
61,84Â US$
Beta
0,87
Aksionet në qarkullim
480,40Â mln
Numri i punonjësve
25 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
19 orë më parë
Bill Ackman Opened About $2 Billion in New Positions in Alcon and Intercontinental Exchange
Profili
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Rreth Alcon AG
Drejtori ekzekutivDavid J. Endicott
Punonjësit25 mijë
Themeluar më1945
SeliaGjeneva, Kantoni Gjenevë, Zvicër
SektoriHealth Care
IndustriaMedical device
Uebsajtialcon.com